Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off By Ogkologos - January 19, 2026 396 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Tambotatug Pelitecan Leads to Better Clinical Outcomes than Topotecan Among Patients with Relapsed SCLC After Platinum-based Therapy ESMO Welcomes European Parliament Calls to Strengthen and Protect Europe’s Cancer Workforce No improvement in OS, but more grade 3 or higher AEs with atezolizumab plus SBRT among patients with inoperable early-stage NSCLC MOST POPULAR Cancer in My Community: Addressing Regional Cancer Disparities in Peru August 24, 2023 New on NCI’s Websites for July 2021 July 13, 2021 EMA Recommends Granting a Marketing Authorisation for Phesgo (Pertuzumab / Trastuzumab) November 19, 2020 Brentuximab Approved for High-Risk Hodgkin Lymphoma in Children and Adolescents December 15, 2022 Load more HOT NEWS College Basketball Star Plays First Game in Nearly Two Years After... FDA Approves Pembrolizumab for First-Line Treatment of MSI-H/dMMR Colorectal Cancer Trial Results Confirm Effectiveness of Atezolizumab Against a Rare Sarcoma EMA Recommends Granting a Marketing Authorisation for Zolbetuximab
